text:
DNA repair
From Wikipedia, the free encyclopedia
Jump to: navigation, search
For the journal, see DNA Repair (journal).
DNA damage resulting in multiple broken chromosomes
DNA repair is a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encode its genome. In human cells, both normal metabolic activities and environmental factors such as radiation can cause DNA damage, resulting in as many as 1 million individual molecular lesions per cell per day.[1] Many of these lesions cause structural damage to the DNA molecule and can alter or eliminate the cell's ability to transcribe the gene that the affected DNA encodes. Other lesions induce potentially harmful mutations in the cell's genome, which affect the survival of its daughter cells after it undergoes mitosis. As a consequence, the DNA repair process is constantly active as it responds to damage in the DNA structure. When normal repair processes fail, and when cellular apoptosis does not occur, irreparable DNA damage may occur, including double-strand breaks and DNA crosslinkages (interstrand crosslinks or ICLs).[2][3] This can eventually lead to malignant tumors, or cancer as per the two hit hypothesis.
The rate of DNA repair is dependent on many factors, including the cell type, the age of the cell, and the extracellular environment. A cell that has accumulated a large amount of DNA damage, or one that no longer effectively repairs damage incurred to its DNA, can enter one of three possible states:
an irreversible state of dormancy, known as senescence
cell suicide, also known as apoptosis or programmed cell death
unregulated cell division, which can lead to the formation of a tumor that is cancerous
The DNA repair ability of a cell is vital to the integrity of its genome and thus to the normal functionality of that organism. Many genes that were initially shown to influence life span have turned out to be involved in DNA damage repair and protection.[4]
Play media
Paul Modrich
The 2015 Nobel Prize in Chemistry was awarded to Tomas Lindahl, Paul Modrich, and Aziz Sancar for their work on the molecular mechanisms of DNA repair processes.[5][6] There are two types: nucleotide excision repair and base excision repair.
Contents
[hide]
1 DNA damage
1.1 Sources of damage
1.2 Types of damage
1.3 Nuclear versus mitochondrial DNA damage
1.4 Senescence and apoptosis
1.5 DNA damage and mutation
2 DNA repair mechanisms
2.1 Direct reversal
2.2 Single-strand damage
2.3 Double-strand breaks
2.4 Translesion synthesis
3 Global response to DNA damage
3.1 Initial steps
3.2 DNA damage checkpoints
3.3 The prokaryotic SOS response
3.4 Eukaryotic transcriptional responses to DNA damage
4 DNA repair and aging
4.1 Pathological effects of poor DNA repair
4.2 Longevity and caloric restriction
5 Medicine and DNA repair modulation
5.1 Hereditary DNA repair disorders
6 DNA repair and cancer
6.1 DNA repair defects in cancer
6.2 Epigenetic DNA repair defects in cancer
6.3 Frequencies of epimutations in DNA repair genes
6.4 Genome-wide distribution of DNA repair in human somatic cells
7 DNA repair and evolution
7.1 Rate of evolutionary change
8 DNA repair technology
9 See also
10 References
11 External links
DNA damage[edit]
Further information: DNA damage (naturally occurring) and Free radical damage to DNA
DNA damage, due to environmental factors and normal metabolic processes inside the cell, occurs at a rate of 10,000 to 1,000,000 molecular lesions per cell per day.[1] While this constitutes only 0.000165% of the human genome's approximately 6 billion bases (3 billion base pairs), unrepaired lesions in critical genes (such as tumor suppressor genes) can impede a cell's ability to carry out its function and appreciably increase the likelihood of tumor formation and contribute to tumour heterogeneity.
The vast majority of DNA damage affects the primary structure of the double helix; that is, the bases themselves are chemically modified. These modifications can in turn disrupt the molecules' regular helical structure by introducing non-native chemical bonds or bulky adducts that do not fit in the standard double helix. Unlike proteins and RNA, DNA usually lacks tertiary structure and therefore damage or disturbance does not occur at that level. DNA is, however, supercoiled and wound around "packaging" proteins called histones (in eukaryotes), and both superstructures are vulnerable to the effects of DNA damage.
Sources of damage[edit]
DNA damage can be subdivided into two main types:
endogenous damage such as attack by reactive oxygen species produced from normal metabolic byproducts (spontaneous mutation), especially the process of oxidative deamination
also includes replication errors
exogenous damage caused by external agents such as
ultraviolet [UV 200–400 nm] radiation from the sun
other radiation frequencies, including x-rays and gamma rays
hydrolysis or thermal disruption
certain plant toxins
human-made mutagenic chemicals, especially aromatic compounds that act as DNA intercalating agents
viruses[7]
The replication of damaged DNA before cell division can lead to the incorporation of wrong bases opposite damaged ones. Daughter cells that inherit these wrong bases carry mutations from which the original DNA sequence is unrecoverable (except in the rare case of a back mutation, for example, through gene conversion).
Types of damage[edit]
There are several types of damage to DNA due to endogenous cellular processes:
oxidation of bases [e.g. 8-oxo-7,8-dihydroguanine (8-oxoG)] and generation of DNA strand interruptions from reactive oxygen species,
alkylation of bases (usually methylation), such as formation of 7-methylguanosine, 1-methyladenine, 6-O-Methylguanine
hydrolysis of bases, such as deamination, depurination, and depyrimidination.
"bulky adduct formation" (i.e., benzo[a]pyrene diol epoxide-dG adduct, aristolactam I-dA adduct)
mismatch of bases, due to errors in DNA replication, in which the wrong DNA base is stitched into place in a newly forming DNA strand, or a DNA base is skipped over or mistakenly inserted.
Monoadduct damage cause by change in single nitrogenous base of DNA
Diadduct damage
Damage caused by exogenous agents comes in many forms. Some examples are:
UV-B light causes crosslinking between adjacent cytosine and thymine bases creating pyrimidine dimers. This is called direct DNA damage.
UV-A light creates mostly free radicals. The damage caused by free radicals is called indirect DNA damage.
Ionizing radiation such as that created by radioactive decay or in cosmic rays causes breaks in DNA strands. Intermediate-level ionizing radiation may induce irreparable DNA damage (leading to replicational and transcriptional errors needed for neoplasia or may trigger viral interactions) leading to pre-mature aging and cancer.
Thermal disruption at elevated temperature increases the rate of depurination (loss of purine bases from the DNA backbone) and single-strand breaks. For example, hydrolytic depurination is seen in the thermophilic bacteria, which grow in hot springs at 40–80 °C.[8][9] The rate of depurination (300 purine residues per genome per generation) is too high in these species to be repaired by normal repair machinery, hence a possibility of an adaptive response cannot be ruled out.
Industrial chemicals such as vinyl chloride and hydrogen peroxide, and environmental chemicals such as polycyclic aromatic hydrocarbons found in smoke, soot and tar create a huge diversity of DNA adducts- ethenobases, oxidized bases, alkylated phosphotriesters and crosslinking of DNA, just to name a few.
UV damage, alkylation/methylation, X-ray damage and oxidative damage are examples of induced damage. Spontaneous damage can include the loss of a base, deamination, sugar ring puckering and tautomeric shift.
Nuclear versus mitochondrial DNA damage[edit]
In human cells, and eukaryotic cells in general, DNA is found in two cellular locations — inside the nucleus and inside the mitochondria. Nuclear DNA (nDNA) exists as chromatin during non-replicative stages of the cell cycle and is condensed into aggregate structures known as chromosomes during cell division. In either state the DNA is highly compacted and wound up around bead-like proteins called histones. Whenever a cell needs to express the genetic information encoded in its nDNA the required chromosomal region is unravelled, genes located therein are expressed, and then the region is condensed back to its resting conformation. Mitochondrial DNA (mtDNA) is located inside mitochondria organelles, exists in multiple copies, and is also tightly associated with a number of proteins to form a complex known as the nucleoid. Inside mitochondria, reactive oxygen species (ROS), or free radicals, byproducts of the constant production of adenosine triphosphate (ATP) via oxidative phosphorylation, create a highly oxidative environment that is known to damage mtDNA. A critical enzyme in counteracting the toxicity of these species is superoxide dismutase, which is present in both the mitochondria and cytoplasm of eukaryotic cells.
Senescence and apoptosis[edit]
Senescence, an irreversible process in which the cell no longer divides, is a protective response to the shortening of the chromosome ends. The telomeres are long regions of repetitive noncoding DNA that cap chromosomes and undergo partial degradation each time a cell undergoes division (see Hayflick limit).[10] In contrast, quiescence is a reversible state of cellular dormancy that is unrelated to genome damage (see cell cycle). Senescence in cells may serve as a functional alternative to apoptosis in cases where the physical presence of a cell for spatial reasons is required by the organism,[11] which serves as a "last resort" mechanism to prevent a cell with damaged DNA from replicating inappropriately in the absence of pro-growth cellular signaling. Unregulated cell division can lead to the formation of a tumor (see cancer), which is potentially lethal to an organism. Therefore, the induction of senescence and apoptosis is considered to be part of a strategy of protection against cancer.[12]
DNA damage and mutation[edit]
It is important to distinguish between DNA damage and mutation, the two major types of error in DNA. DNA damage and mutation are fundamentally different. Damage results in physical abnormalities in the DNA, such as single- and double-strand breaks, 8-hydroxydeoxyguanosine residues, and polycyclic aromatic hydrocarbon adducts. DNA damage can be recognized by enzymes, and thus can be correctly repaired if redundant information, such as the undamaged sequence in the complementary DNA strand or in a homologous chromosome, is available for copying. If a cell retains DNA damage, transcription of a gene can be prevented, and thus translation into a protein will also be blocked. Replication may also be blocked or the cell may die.
In contrast to DNA damage, a mutation is a change in the base sequence of the DNA. A mutation cannot be recognized by enzymes once the base change is present in both DNA strands, and thus a mutation cannot be repaired. At the cellular level, mutations can cause alterations in protein function and regulation. Mutations are replicated when the cell replicates. In a population of cells, mutant cells will increase or decrease in frequency according to the effects of the mutation on the ability of the cell to survive and reproduce.
Although distinctly different from each other, DNA damage and mutation are related because DNA damage often causes errors of DNA synthesis during replication or repair; these errors are a major source of mutation.
Given these properties of DNA damage and mutation, it can be seen that DNA damage is a special problem in non-dividing or slowly-dividing cells, where unrepaired damage will tend to accumulate over time. On the other hand, in rapidly-dividing cells, unrepaired DNA damage that does not kill the cell by blocking replication will tend to cause replication errors and thus mutation. The great majority of mutations that are not neutral in their effect are deleterious to a cell's survival. Thus, in a population of cells composing a tissue with replicating cells, mutant cells will tend to be lost. However, infrequent mutations that provide a survival advantage will tend to clonally expand at the expense of neighboring cells in the tissue. This advantage to the cell is disadvantageous to the whole organism, because such mutant cells can give rise to cancer. Thus, DNA damage in frequently dividing cells, because it gives rise to mutations, is a prominent cause of cancer. In contrast, DNA damage in infrequently-dividing cells is likely a prominent cause of aging.[13]
DNA repair mechanisms[edit]
Cells cannot function if DNA damage corrupts the integrity and accessibility of essential information in the genome (but cells remain superficially functional when non-essential genes are missing or damaged). Depending on the type of damage inflicted on the DNA's double helical structure, a variety of repair strategies have evolved to restore lost information. If possible, cells use the unmodified complementary strand of the DNA or the sister chromatid as a template to recover the original information. Without access to a template, cells use an error-prone recovery mechanism known as translesion synthesis as a last resort.
Damage to DNA alters the spatial configuration of the helix, and such alterations can be detected by the cell. Once damage is localized, specific DNA repair molecules bind at or near the site of damage, inducing other molecules to bind and form a complex that enables the actual repair to take place.
Direct reversal[edit]
Cells are known to eliminate three types of damage to their DNA by chemically reversing it. These mechanisms do not require a template, since the types of damage they counteract can occur in only one of the four bases. Such direct reversal mechanisms are specific to the type of damage incurred and do not involve breakage of the phosphodiester backbone. The formation of pyrimidine dimers upon irradiation with UV light results in an abnormal covalent bond between adjacent pyrimidine bases. The photoreactivation process directly reverses this damage by the action of the enzyme photolyase, whose activation is obligately dependent on energy absorbed from blue/UV light (300–500 nm wavelength) to promote catalysis.[14] Photolyase, an old enzyme present in bacteria, fungi, and most animals no longer functions in humans,[15] who instead use nucleotide excision repair to repair damage from UV irradiation. Another type of damage, methylation of guanine bases, is directly reversed by the protein methyl guanine methyl transferase (MGMT), the bacterial equivalent of which is called ogt. This is an expensive process because each MGMT molecule can be used only once; that is, the reaction is stoichiometric rather than catalytic.[16] A generalized response to methylating agents in bacteria is known as the adaptive response and confers a level of resistance to alkylating agents upon sustained exposure by upregulation of alkylation repair enzymes.[17] The third type of DNA damage reversed by cells is certain methylation of the bases cytosine and adenine.
Single-strand damage[edit]
Structure of the base-excision repair enzyme uracil-DNA glycosylase excising a hydrolytically-produced uracil residue from DNA. The uracil residue is shown in yellow.
When only one of the two strands of a double helix has a defect, the other strand can be used as a template to guide the correction of the damaged strand. In order to repair damage to one of the two paired molecules of DNA, there exist a number of excision repair mechanisms that remove the damaged nucleotide and replace it with an undamaged nucleotide complementary to that found in the undamaged DNA strand.[16]
Base excision repair (BER) repairs damage to a single nitrogenous base by deploying enzymes called glycosylases.[18] These enzymes remove a single nitrogenous base to create an apurinic or apyrimidinic site (AP site).[18] Enzymes called AP endonucleases nick the damaged DNA backbone at the AP site. DNA polymerase then removes the damaged region using its 5’ to 3’ exonuclease activity and correctly synthesizes the new strand using the complementary strand as a template.[18]
Nucleotide excision repair (NER) repairs damaged DNA which commonly consists of bulky, helix-distorting damage, such as pyrimidine dimerization caused by UV light. Damaged regions are removed in 12–24 nucleotide-long strands in a three-step process which consists of recognition of damage, excision of damaged DNA both upstream and downstream of damage by endonucleases, and resynthesis of removed DNA region.[19] NER is a highly evolutionarily conserved repair mechanism and is used in nearly all eukaryotic and prokaryotic cells.[19] In prokaryotes, NER is mediated by Uvr proteins.[19] In eukaryotes, many more proteins are involved, although the general strategy is the same.[19]
Mismatch repair systems are present in essentially all cells to correct errors that are not corrected by proofreading. These systems consist of at least two proteins. One detects the mismatch, and the other recruits an endonuclease that cleaves the newly synthesized DNA strand close to the region of damage. In E. coli , the proteins involved are the Mut class proteins. This is followed by removal of damaged region by an exonuclease, resynthesis by DNA polymerase, and nick sealing by DNA ligase.[20]
Double-strand breaks[edit]
Double-strand breaks, in which both strands in the double helix are severed, are particularly hazardous to the cell because they can lead to genome rearrangements. PVN Acharya noted that double-strand breaks and a "cross-linkage joining both strands at the same point is irreparable because neither strand can then serve as a template for repair. The cell will die in the next mitosis or in some rare instances, mutate."[2][3] Three mechanisms exist to repair double-strand breaks (DSBs): non-homologous end joining (NHEJ), microhomology-mediated end joining (MMEJ), and homologous recombination.[16][21] In an in vitro system, MMEJ occurred in mammalian cells at the levels of 10–20% of HR when both HR and NHEJ mechanisms were also available.[22]
DNA ligase, shown above repairing chromosomal damage, is an enzyme that joins broken nucleotides together by catalyzing the formation of an internucleotide ester bond between the phosphate backbone and the deoxyribose nucleotides.
In NHEJ, DNA Ligase IV, a specialized DNA ligase that forms a complex with the cofactor XRCC4, directly joins the two ends.[23] To guide accurate repair, NHEJ relies on short homologous sequences called microhomologies present on the single-stranded tails of the DNA ends to be joined. If these overhangs are compatible, repair is usually accurate.[24][25][26][27] NHEJ can also introduce mutations during repair. Loss of damaged nucleotides at the break site can lead to deletions, and joining of nonmatching termini forms insertions or translocations. NHEJ is especially important before the cell has replicated its DNA, since there is no template available for repair by homologous recombination. There are "backup" NHEJ pathways in higher eukaryotes.[28] Besides its role as a genome caretaker, NHEJ is required for joining hairpin-capped double-strand breaks induced during V(D)J recombination, the process that generates diversity in B-cell and T-cell receptors in the vertebrate immune system.[29]
Homologous recombination requires the presence of an identical or nearly identical sequence to be used as a template for repair of the break. The enzymatic machinery responsible for this repair process is nearly identical to the machinery responsible for chromosomal crossover during meiosis. This pathway allows a damaged chromosome to be repaired using a sister chromatid (available in G2 after DNA replication) or a homologous chromosome as a template. DSBs caused by the replication machinery attempting to synthesize across a single-strand break or unrepaired lesion cause collapse of the replication fork and are typically repaired by recombination.
MMEJ starts with short-range end resection by MRE11 nuclease on either side of a double-strand break to reveal microhomology regions.[22] In further steps,[30] Poly (ADP-ribose) polymerase 1 (PARP1) is required and may be an early step in MMEJ. There is pairing of microhomology regions followed by recruitment of flap structure-specific endonuclease 1 (FEN1) to remove overhanging flaps. This is followed by recruitment of XRCC1–LIG3 to the site for ligating the DNA ends, leading to an intact DNA. MMEJ is always accompanied by a deletion, so that MMEJ is a mutagenic pathway for DNA repair.[31]
The extremophile Deinococcus radiodurans has a remarkable ability to survive DNA damage from ionizing radiation and other sources. At least two copies of the genome, with random DNA breaks, can form DNA fragments through annealing. Partially overlapping fragments are then used for synthesis of homologous regions through a moving D-loop that can continue extension until they find complementary partner strands. In the final step there is crossover by means of RecA-dependent homologous recombination.[32]
Topoisomerases introduce both single- and double-strand breaks in the course of changing the DNA's state of supercoiling, which is especially common in regions near an open replication fork. Such breaks are not considered DNA damage because they are a natural intermediate in the topoisomerase biochemical mechanism and are immediately repaired by the enzymes that created them.
Translesion synthesis[edit]
Translesion synthesis (TLS) is a DNA damage tolerance process that allows the DNA replication machinery to replicate past DNA lesions such as thymine dimers or AP sites.[33] It involves switching out regular DNA polymerases for specialized translesion polymerases (i.e. DNA polymerase IV or V, from the Y Polymerase family), often with larger active sites that can facilitate the insertion of bases opposite damaged nucleotides. The polymerase switching is thought to be mediated by, among other factors, the post-translational modification of the replication processivity factor PCNA. Translesion synthesis polymerases often have low fidelity (high propensity to insert wrong bases) on undamaged templates relative to regular polymerases. However, many are extremely efficient at inserting correct bases opposite specific types of damage. For example, Pol η mediates error-free bypass of lesions induced by UV irradiation, whereas Pol ι introduces mutations at these sites. Pol η is known to add the first adenine across the T^T photodimer using Watson-Crick base pairing and the second adenine will be added in its syn conformation using Hoogsteen base pairing. From a cellular perspective, risking the introduction of point mutations during translesion synthesis may be preferable to resorting to more drastic mechanisms of DNA repair, which may cause gross chromosomal aberrations or cell death. In short, the process involves specialized polymerases either bypassing or repairing lesions at locations of stalled DNA replication. For example, Human DNA polymerase eta can bypass complex DNA lesions like guanine-thymine intra-strand crosslink, G[8,5-Me]T, although can cause targeted and semi-targeted mutations.[34] Paromita Raychaudhury and Ashis Basu[35] studied the toxicity and mutagenesis of the same lesion in Escherichia coli by replicating a G[8,5-Me]T-modified plasmid in E. coli with specific DNA polymerase knockouts. Viability was very low in a strain lacking pol II, pol IV, and pol V, the three SOS-inducible DNA polymerases, indicating that translesion synthesis is conducted primarily by these specialized DNA polymerases. A bypass platform is provided to these polymerases by Proliferating cell nuclear antigen (PCNA). Under normal circumstances, PCNA bound to polymerases replicates the DNA. At a site of lesion, PCNA is ubiquitinated, or modified, by the RAD6/RAD18 proteins to provide a platform for the specialized polymerases to bypass the lesion and resume DNA replication.[36][37] After translesion synthesis, extension is required. This extension can be carried out by a replicative polymerase if the TLS is error-free, as in the case of Pol η, yet if TLS results in a mismatch, a specialized polymerase is needed to extend it; Pol ζ. Pol ζ is unique in that it can extend terminal mismatches, whereas more processive polymerases cannot. So when a lesion is encountered, the replication fork will stall, PCNA will switch from a processive polymerase to a TLS polymerase such as Pol ι to fix the lesion, then PCNA may switch to Pol ζ to extend the mismatch, and last PCNA will switch to the processive polymerase to continue replication.
Global response to DNA damage[edit]
Cells exposed to ionizing radiation, ultraviolet light or chemicals are prone to acquire multiple sites of bulky DNA lesions and double-strand breaks. Moreover, DNA damaging agents can damage other biomolecules such as proteins, carbohydrates, lipids, and RNA. The accumulation of damage, to be specific, double-strand breaks or adducts stalling the replication forks, are among known stimulation signals for a global response to DNA damage.[38] The global response to damage is an act directed toward the cells' own preservation and triggers multiple pathways of macromolecular repair, lesion bypass, tolerance, or apoptosis. The common features of global response are induction of multiple genes, cell cycle arrest, and inhibition of cell division.
Initial steps[edit]
The packaging of eukaryotic DNA into chromatin presents a barrier to all DNA-based processes that require recruitment of enzymes to their sites of action. To allow DNA repair, the chromatin must be remodeled. In eukaryotes, ATP dependent chromatin remodeling complexes and histone-modifying enzymes are two predominant factors employed to accomplish this remodeling process.[39]
Chromatin relaxation occurs rapidly at the site of a DNA damage.[40] In one of the earliest steps, the stress-activated protein kinase, c-Jun N-terminal kinase (JNK), phosphorylates SIRT6 on serine 10 in response to double-strand breaks or other DNA damage.[41] This post-translational modification facilitates the mobilization of SIRT6 to DNA damage sites, and is required for efficient recruitment of poly (ADP-ribose) polymerase 1 (PARP1) to DNA break sites and for efficient repair of DSBs.[41] PARP1 protein starts to appear at DNA damage sites in less than a second, with half maximum accumulation within 1.6 seconds after the damage occurs.[42] PARP1 synthesizes polymeric adenosine diphosphate ribose (poly (ADP-ribose) or PAR) chains on itself. Next the chromatin remodeler ALC1 quickly attaches to the product of PARP1 action, a poly-ADP ribose chain, and ALC1 completes arrival at the DNA damage within 10 seconds of the occurrence of the damage.[40] About half of the maximum chromatin relaxation, presumably due to action of ALC1, occurs by 10 seconds.[40] This then allows recruitment of the DNA repair enzyme MRE11, to initiate DNA repair, within 13 seconds.[42]
γH2AX, the phosphorylated form of H2AX is also involved in the early steps leading to chromatin decondensation after DNA double-strand breaks. The histone variant H2AX constitutes about 10% of the H2A histones in human chromatin.[43] γH2AX (H2AX phosphorylated on serine 139) can be detected as soon as 20 seconds after irradiation of cells (with DNA double-strand break formation), and half maximum accumulation of γH2AX occurs in one minute.[43] The extent of chromatin with phosphorylated γH2AX is about two million base pairs at the site of a DNA double-strand break.[43] γH2AX does not, itself, cause chromatin decondensation, but within 30 seconds of irradiation, RNF8 protein can be detected in association with γH2AX.[44] RNF8 mediates extensive chromatin decondensation, through its subsequent interaction with CHD4,[45] a component of the nucleosome remodeling and deacetylase complex NuRD.
DDB2 occurs in a heterodimeric complex with DDB1. This complex further complexes with the ubiquitin ligase protein CUL4A[46] and with PARP1.[47] This larger complex rapidly associates with UV-induced damage within chromatin, with half-maximum association completed in 40 seconds.[46] The PARP1 protein, attached to both DDB1 and DDB2, then PARylates (creates a poly-ADP ribose chain) on DDB2 that attracts the DNA remodeling protein ALC1.[47] Action of ALC1 relaxes the chromatin at the site of UV damage to DNA. This relaxation allows other proteins in the nucleotide excision repair pathway to enter the chromatin and repair UV-induced cyclobutane pyrimidine dimer damages.
After rapid chromatin remodeling, cell cycle checkpoints are activated to allow DNA repair to occur before the cell cycle progresses. First, two kinases, ATM and ATR are activated within 5 or 6 minutes after DNA is damaged. This is followed by phosphorylation of the cell cycle checkpoint protein Chk1, initiating its function, about 10 minutes after DNA is damaged.[48]
DNA damage checkpoints[edit]
After DNA damage, cell cycle checkpoints are activated. Checkpoint activation pauses the cell cycle and gives the cell time to repair the damage before continuing to divide. DNA damage checkpoints occur at the G1/S and G2/M boundaries. An intra-S checkpoint also exists. Checkpoint activation is controlled by two master kinases, ATM and ATR. ATM responds to DNA double-strand breaks and disruptions in chromatin structure,[49] whereas ATR primarily responds to stalled replication forks. These kinases phosphorylate downstream targets in a signal transduction cascade, eventually leading to cell cycle arrest. A class of checkpoint mediator proteins including BRCA1, MDC1, and 53BP1 has also been identified.[50] These proteins seem to be required for transmitting the checkpoint activation signal to downstream proteins.
DNA damage checkpoint is a signal transduction pathway that blocks cell cycle progression in G1, G2 and metaphase and slows down the rate of S phase progression when DNA is damaged. It leads to a pause in cell cycle allowing the cell time to repair the damage before continuing to divide.
Checkpoint Proteins can be separated into four groups: phosphatidylinositol 3-kinase (PI3K)-like protein kinase, proliferating cell nuclear antigen (PCNA)-like group, two serine/threonine(S/T) kinases and their adaptors. Central to all DNA damage induced checkpoints responses is a pair of large protein kinases belonging to the first group of PI3K-like protein kinases-the ATM (Ataxia telangiectasia mutated) and ATR (Ataxia- and Rad-related) kinases, whose sequence and functions have been well conserved in evolution. All DNA damage response requires either ATM or ATR because they have the ability to bind to the chromosomes at the site of DNA damage, together with accessory proteins that are platforms on which DNA damage response components and DNA repair complexes can be assembled.
An important downstream target of ATM and ATR is p53, as it is required for inducing apoptosis following DNA damage.[51] The cyclin-dependent kinase inhibitor p21 is induced by both p53-dependent and p53-independent mechanisms and can arrest the cell cycle at the G1/S and G2/M checkpoints by deactivating cyclin/cyclin-dependent kinase complexes.[52]
The prokaryotic SOS response[edit]
The SOS response is the changes in gene expression in Escherichia coli and other bacteria in response to extensive DNA damage. The prokaryotic SOS system is regulated by two key proteins: LexA and RecA. The LexA homodimer is a transcriptional repressor that binds to operator sequences commonly referred to as SOS boxes. In Escherichia coli it is known that LexA regulates transcription of approximately 48 genes including the lexA and recA genes.[53] The SOS response is known to be widespread in the Bacteria domain, but it is mostly absent in some bacterial phyla, like the Spirochetes.[54] The most common cellular signals activating the SOS response are regions of single-stranded DNA (ssDNA), arising from stalled replication forks or double-strand breaks, which are processed by DNA helicase to separate the two DNA strands.[38] In the initiation step, RecA protein binds to ssDNA in an ATP hydrolysis driven reaction creating RecA–ssDNA filaments. RecA–ssDNA filaments activate LexA autoprotease activity, which ultimately leads to cleavage of LexA dimer and subsequent LexA degradation. The loss of LexA repressor induces transcription of the SOS genes and allows for further signal induction, inhibition of cell division and an increase in levels of proteins responsible for damage processing.
In Escherichia coli, SOS boxes are 20-nucleotide long sequences near promoters with palindromic structure and a high degree of sequence conservation. In other classes and phyla, the sequence of SOS boxes varies considerably, with different length and composition, but it is always highly conserved and one of the strongest short signals in the genome.[54] The high information content of SOS boxes permits differential binding of LexA to different promoters and allows for timing of the SOS response. The lesion repair genes are induced at the beginning of SOS response. The error-prone translesion polymerases, for example, UmuCD'2 (also called DNA polymerase V), are induced later on as a last resort.[55] Once the DNA damage is repaired or bypassed using polymerases or through recombination, the amount of single-stranded DNA in cells is decreased, lowering the amounts of RecA filaments decreases cleavage activity of LexA homodimer, which then binds to the SOS boxes near promoters and restores normal gene expression.
Eukaryotic transcriptional responses to DNA damage[edit]
Eukaryotic cells exposed to DNA damaging agents also activate important defensive pathways by inducing multiple proteins involved in DNA repair, cell cycle checkpoint control, protein trafficking and degradation. Such genome wide transcriptional response is very complex and tightly regulated, thus allowing coordinated global response to damage. Exposure of yeast Saccharomyces cerevisiae to DNA damaging agents results in overlapping but distinct transcriptional profiles. Similarities to environmental shock response indicates that a general global stress response pathway exist at the level of transcriptional activation. In contrast, different human cell types respond to damage differently indicating an absence of a common global response. The probable explanation for this difference between yeast and human cells may be in the heterogeneity of mammalian cells. In an animal different types of cells are distributed among different organs that have evolved different sensitivities to DNA damage.[56]
In general global response to DNA damage involves expression of multiple genes responsible for postreplication repair, homologous recombination, nucleotide excision repair, DNA damage checkpoint, global transcriptional activation, genes controlling mRNA decay, and many others. A large amount of damage to a cell leaves it with an important decision: undergo apoptosis and die, or survive at the cost of living with a modified genome. An increase in tolerance to damage can lead to an increased rate of survival that will allow a greater accumulation of mutations. Yeast Rev1 and human polymerase η are members of [Y family translesion DNA polymerases present during global response to DNA damage and are responsible for enhanced mutagenesis during a global response to DNA damage in eukaryotes.[38]
DNA repair and aging[edit]
Main article: DNA damage theory of aging
Pathological effects of poor DNA repair[edit]
DNA repair rate is an important determinant of cell pathology
Experimental animals with genetic deficiencies in DNA repair often show decreased life span and increased cancer incidence.[13] For example, mice deficient in the dominant NHEJ pathway and in telomere maintenance mechanisms get lymphoma and infections more often, and, as a consequence, have shorter lifespans than wild-type mice.[57] In similar manner, mice deficient in a key repair and transcription protein that unwinds DNA helices have premature onset of aging-related diseases and consequent shortening of lifespan.[58] However, not every DNA repair deficiency creates exactly the predicted effects; mice deficient in the NER pathway exhibited shortened life span without correspondingly higher rates of mutation.[59]
If the rate of DNA damage exceeds the capacity of the cell to repair it, the accumulation of errors can overwhelm the cell and result in early senescence, apoptosis, or cancer. Inherited diseases associated with faulty DNA repair functioning result in premature aging,[13] increased sensitivity to carcinogens, and correspondingly increased cancer risk (see below). On the other hand, organisms with enhanced DNA repair systems, such as Deinococcus radiodurans, the most radiation-resistant known organism, exhibit remarkable resistance to the double-strand break-inducing effects of radioactivity, likely due to enhanced efficiency of DNA repair and especially NHEJ.[60]
Longevity and caloric restriction[edit]
Most life span influencing genes affect the rate of DNA damage
A number of individual genes have been identified as influencing variations in life span within a population of organisms. The effects of these genes is strongly dependent on the environment, in particular, on the organism's diet. Caloric restriction reproducibly results in extended lifespan in a variety of organisms, likely via nutrient sensing pathways and decreased metabolic rate. The molecular mechanisms by which such restriction results in lengthened lifespan are as yet unclear (see[61] for some discussion); however, the behavior of many genes known to be involved in DNA repair is altered under conditions of caloric restriction. Several agents reported to have anti-aging properties have been shown to attenuate constitutive level of mTOR signaling, an evidence of reduction of metabolic activity, and concurrently to reduce constitutive level of DNA damage] induced by endogenously generated reactive oxygen species. [62]
For example, increasing the gene dosage of the gene SIR-2, which regulates DNA packaging in the nematode worm Caenorhabditis elegans, can significantly extend lifespan.[63] The mammalian homolog of SIR-2 is known to induce downstream DNA repair factors involved in NHEJ, an activity that is especially promoted under conditions of caloric restriction.[64] Caloric restriction has been closely linked to the rate of base excision repair in the nuclear DNA of rodents,[65] although similar effects have not been observed in mitochondrial DNA.[66]
The C. elegans gene AGE-1, an upstream effector of DNA repair pathways, confers dramatically extended life span under free-feeding conditions but leads to a decrease in reproductive fitness under conditions of caloric restriction.[67] This observation supports the pleiotropy theory of the biological origins of aging, which suggests that genes conferring a large survival advantage early in life will be selected for even if they carry a corresponding disadvantage late in life.
Medicine and DNA repair modulation[edit]
Main article: DNA repair-deficiency disorder
Hereditary DNA repair disorders[edit]
Defects in the NER mechanism are responsible for several genetic disorders, including:
Xeroderma pigmentosum: hypersensitivity to sunlight/UV, resulting in increased skin cancer incidence and premature aging
Cockayne syndrome: hypersensitivity to UV and chemical agents
Trichothiodystrophy: sensitive skin, brittle hair and nails
Mental retardation often accompanies the latter two disorders, suggesting increased vulnerability of developmental neurons.
Other DNA repair disorders include:
Werner's syndrome: premature aging and retarded growth
Bloom's syndrome: sunlight hypersensitivity, high incidence of malignancies (especially leukemias).
Ataxia telangiectasia: sensitivity to ionizing radiation and some chemical agents
All of the above diseases are often called "segmental progerias" ("accelerated aging diseases") because their victims appear elderly and suffer from aging-related diseases at an abnormally young age, while not manifesting all the symptoms of old age.
Other diseases associated with reduced DNA repair function include Fanconi anemia, hereditary breast cancer and hereditary colon cancer.
DNA repair and cancer[edit]
Because of inherent limitations in the DNA repair mechanisms, if humans lived long enough, they would all eventually develop cancer.[68][69] There are at least 34 Inherited human DNA repair gene mutations that increase cancer risk. Many of these mutations cause DNA repair to be less effective than normal. In particular, Hereditary nonpolyposis colorectal cancer (HNPCC) is strongly associated with specific mutations in the DNA mismatch repair pathway. BRCA1 and BRCA2, two famous genes whose mutations confer a hugely increased risk of breast cancer on carriers, are both associated with a large number of DNA repair pathways, especially NHEJ and homologous recombination.
Cancer therapy procedures such as chemotherapy and radiotherapy work by overwhelming the capacity of the cell to repair DNA damage, resulting in cell death. Cells that are most rapidly dividing — most typically cancer cells — are preferentially affected. The side-effect is that other non-cancerous but rapidly dividing cells such as progenitor cells in the gut, skin, and hematopoietic system are also affected. Modern cancer treatments attempt to localize the DNA damage to cells and tissues only associated with cancer, either by physical means (concentrating the therapeutic agent in the region of the tumor) or by biochemical means (exploiting a feature unique to cancer cells in the body). …; in the context of therapies targeting DNA damage response genes, the latter approach has been termed ‘synthetic lethality’.[70]
Perhaps the most well-known of these 'synthetic lethality' drugs is the poly(ADP-ribose) polymerase 1 (PARP1) inhibitor olaparib, which was approved by the Food and Drug Administration in 2015 for the treatment in women of BRCA-defective ovarian cancer. Tumor cells with partial loss of DNA damage response (specifically, homologous recombination repair) are dependent on another mechanism – single-strand break repair – which is a mechanism consisting, in part, of the PARP1 gene product.[71] Olaparib is combined with chemotherapeutics to inhibit single-strand break repair induced by DNA damage caused by the co-administered chemotherapy. Tumor cells relying on this residual DNA repair mechanism are unable to repair the damage and hence are not able to survive and proliferate, whereas normal cells can repair the damage with the functioning homologous recombination mechanism.
Many other drugs for use against other residual DNA repair mechanisms commonly found in cancer are currently under investigation. However, synthetic lethality therapeutic approaches have been questioned due to emerging evidence of acquired resistance, achieved through rewiring of DNA damage response pathways and reversion of previously-inhibited defects.[72]
DNA repair defects in cancer[edit]
It has become apparent over the past several years that the DNA damage response acts as a barrier to the malignant transformation of preneoplastic cells.[73] Previous studies have shown an elevated DNA damage response in cell-culture models with oncogene activation[74] and preneoplastic colon adenomas.[75] DNA damage response mechanisms trigger cell-cycle arrest, and attempt to repair DNA lesions or promote cell death/senescence if repair is not possible. Replication stress is observed in preneoplastic cells due to increased proliferation signals from oncogenic mutations. Replication stress is characterized by: increased replication initiation/origin firing; increased transcription and collisions of transcription-replication complexes; nucleotide deficiency; increase in reactive oxygen species (ROS).[76]
Replication stress, along with the selection for inactivating mutations in DNA damage response genes in the evolution of the tumor,[77] leads to downregulation and/or loss of some DNA damage response mechanisms, and hence loss of DNA repair and/or senescence/programmed cell death. In experimental mouse models, loss of DNA damage response-mediated cell senescence was observed after using a short hairpin RNA (shRNA) to inhibit the double-strand break response kinase ataxia telangiectasia (ATM), leading to increased tumor size and invasiveness.[75] Humans born with inherited defects in DNA repair mechanisms (for example, Li-Fraumeni syndrome) have a higher cancer risk.[78]
The prevalence of DNA damage response mutations differs across cancer types; for example, 30% of breast invasive carcinomas have mutations in genes involved in homologous recombination.[73] In cancer, downregulation is observed across all DNA damage response mechanisms (base excision repair (BER), nucleotide excision repair (NER), DNA mismatch repair (MMR), homologous recombination repair (HR), non-homologous end joining (NHEJ) and translesion DNA synthesis (TLS).[79] As well as mutations to DNA damage repair genes, mutations also arise in the genes responsible for arresting the cell cycle to allow sufficient time for DNA repair to occur, and some genes are involved in both DNA damage repair and cell cycle checkpoint control, for example ATM and checkpoint kinase 2 (CHEK2) – a tumor suppressor that is often absent or downregulated in non-small cell lung cancer.[80]
HR
NHEJ
SSA
FA
BER
NER
MMR
ATM x x x
ATR x x x
PAXIP x x
RPA x x x
BRCA1 x x
BRCA2 x x
RAD51 x x
RFC x x x
XRCC1 x x
PCNA x x x
PARP1 x x
ERCC1 x x x x
MSH3 x x x
Table: Genes involved in DNA damage response pathways and frequently mutated in cancer (HR = homologous recombination; NHEJ = non-homologous end joining; SSA = single-strand annealing; FA = fanconi anemia pathway; BER = base excision repair; NER = nucleotide excision repair; MMR = mismatch repair)
Epigenetic DNA repair defects in cancer[edit]
Classically, cancer has been viewed as a set of diseases that are driven by progressive genetic abnormalities that include mutations in tumour-suppressor genes and oncogenes, and chromosomal aberrations. However, it has become apparent that cancer is also driven by epigenetic alterations.[81]
Epigenetic alterations refer to functionally relevant modifications to the genome that do not involve a change in the nucleotide sequence. Examples of such modifications are changes in DNA methylation (hypermethylation and hypomethylation) and histone modification,[82] changes in chromosomal architecture (caused by inappropriate expression of proteins such as HMGA2 or HMGA1)[83] and changes caused by microRNAs. Each of these epigenetic alterations serves to regulate gene expression without altering the underlying DNA sequence. These changes usually remain through cell divisions, last for multiple cell generations, and can be considered to be epimutations (equivalent to mutations).
While large numbers of epigenetic alterations are found in cancers, the epigenetic alterations in DNA repair genes, causing reduced expression of DNA repair proteins, appear to be particularly important. Such alterations are thought to occur early in progression to cancer and to be a likely cause of the genetic instability characteristic of cancers.[84][85][86][87]
Reduced expression of DNA repair genes causes deficient DNA repair. When DNA repair is deficient DNA damages remain in cells at a higher than usual level and these excess damages cause increased frequencies of mutation or epimutation. Mutation rates increase substantially in cells defective in DNA mismatch repair[88][89] or in homologous recombinational repair (HRR).[90] Chromosomal rearrangements and aneuploidy also increase in HRR defective cells.[91]
Higher levels of DNA damage not only cause increased mutation, but also cause increased epimutation. During repair of DNA double strand breaks, or repair of other DNA damages, incompletely cleared sites of repair can cause epigenetic gene silencing.[92][93]
Deficient expression of DNA repair proteins due to an inherited mutation can cause increased risk of cancer. Individuals with an inherited impairment in any of 34 DNA repair genes (see article DNA repair-deficiency disorder) have an increased risk of cancer, with some defects causing up to a 100% lifetime chance of cancer (e.g. p53 mutations).[94] However, such germline mutations (which cause highly penetrant cancer syndromes) are the cause of only about 1 percent of cancers.[95]
Frequencies of epimutations in DNA repair genes[edit]
A chart of common DNA damaging agents, examples of lesions they cause in DNA, and pathways used to repair these lesions. Also shown are many of the genes in these pathways, an indication of which genes are epigenetically regulated to have reduced (or increased) expression in various cancers. It also shows genes in the error prone microhomology-mediated end joining pathway with increased expression in various cancers.
Deficiencies in DNA repair enzymes are occasionally caused by a newly arising somatic mutation in a DNA repair gene, but are much more frequently caused by epigenetic alterations that reduce or silence expression of DNA repair genes. For example, when 113 colorectal cancers were examined in sequence, only four had a missense mutation in the DNA repair gene MGMT, while the majority had reduced MGMT expression due to methylation of the MGMT promoter region (an epigenetic alteration).[96] Five different studies found that between 40% and 90% of colorectal cancers have reduced MGMT expression due to methylation of the MGMT promoter region.[97][98][99][100][101]
Similarly, out of 119 cases of mismatch repair-deficient colorectal cancers that lacked DNA repair gene PMS2 expression, PMS2 was deficient in 6 due to mutations in the PMS2 gene, while in 103 cases PMS2 expression was deficient because its pairing partner MLH1 was repressed due to promoter methylation (PMS2 protein is unstable in the absence of MLH1).[102] In the other 10 cases, loss of PMS2 expression was likely due to epigenetic overexpression of the microRNA, miR-155, which down-regulates MLH1.[103]
In further examples (tabulated in Table 4 of this reference[104]), epigenetic defects were found at frequencies of between 13%–100% for the DNA repair genes BRCA1, WRN, FANCB, FANCF, MGMT, MLH1, MSH2, MSH4, ERCC1, XPF, NEIL1 and ATM. These epigenetic defects occurred in various cancers (e.g. breast, ovarian, colorectal and head and neck). Two or three deficiencies in the expression of ERCC1, XPF or PMS2 occur simultaneously in the majority of the 49 colon cancers evaluated by Facista et al.[105]
The chart in this section shows some frequent DNA damaging agents, examples of DNA lesions they cause, and the pathways that deal with these DNA damages. At least 169 enzymes are either directly employed in DNA repair or influence DNA repair processes.[106] Of these, 83 are directly employed in repairing the 5 types of DNA damages illustrated in the chart.
Some of the more well studied genes central to these repair processes are shown in the chart. The gene designations shown in red, gray or cyan indicate genes frequently epigenetically altered in various types of cancers. Wikipedia articles on each of the genes highlighted by red, gray or cyan describe the epigenetic alteration(s) and the cancer(s) in which these epimutations are found. Two review articles,[104][107] and two broad experimental survey articles[108][109] also document most of these epigenetic DNA repair deficiencies in cancers.
Red-highlighted genes are frequently reduced or silenced by epigenetic mechanisms in various cancers. When these genes have low or absent expression, DNA damages can accumulate. Replication errors past these damages (see translesion synthesis) can lead to increased mutations and, ultimately, cancer. Epigenetic repression of DNA repair genes in accurate DNA repair pathways appear to be central to carcinogenesis.
The two gray-highlighted genes RAD51 and BRCA2, are required for homologous recombinational repair. They are sometimes epigenetically over-expressed and sometimes under-expressed in certain cancers. As indicated in the Wikipedia articles on RAD51 and BRCA2, such cancers ordinarily have epigenetic deficiencies in other DNA repair genes. These repair deficiencies would likely cause increased unrepaired DNA damages. The over-expression of RAD51 and BRCA2 seen in these cancers may reflect selective pressures for compensatory RAD51 or BRCA2 over-expression and increased homologous recombinational repair to at least partially deal with such excess DNA damages. In those cases where RAD51 or BRCA2 are under-expressed, this would itself lead to increased unrepaired DNA damages. Replication errors past these damages (see translesion synthesis) could cause increased mutations and cancer, so that under-expression of RAD51 or BRCA2 would be carcinogenic in itself.
Cyan-highlighted genes are in the microhomology-mediated end joining (MMEJ) pathway and are up-regulated in cancer. MMEJ is an additional error-prone inaccurate repair pathway for double-strand breaks. In MMEJ repair of a double-strand break, an homology of 5–25 complementary base pairs between both paired strands is sufficient to align the strands, but mismatched ends (flaps) are usually present. MMEJ removes the extra nucleotides (flaps) where strands are joined, and then ligates the strands to create an intact DNA double helix. MMEJ almost always involves at least a small deletion, so that it is a mutagenic pathway.[110] FEN1, the flap endonuclease in MMEJ, is epigenetically increased by promoter hypomethylation and is over-expressed in the majority of cancers of the breast,[111] prostate,[112] stomach,[113][114] neuroblastomas,[115] pancreas,[116] and lung.[117] PARP1 is also over-expressed when its promoter region ETS site is epigenetically hypomethylated, and this contributes to progression to endometrial cancer,[118] BRCA-mutated ovarian cancer,[119] and BRCA-mutated serous ovarian cancer.[120] Other genes in the MMEJ pathway are also over-expressed in a number of cancers (see MMEJ for summary), and are also shown in cyan.
Genome-wide distribution of DNA repair in human somatic cells[edit]
Differential activity of DNA repair pathways across various regions of the human genome causes mutations to be very unevenly distributed within tumor genomes.[121][122] In particular, the gene-rich, early-replicating regions of the human genome exhibit lower mutation frequencies than the gene-poor, late-replicating heterochromatin. One mechanism underlying this involves the histone modification H3K36me3, which can recruit mismatch repair proteins,[123] thereby lowering mutation rates in H3K36me3-marked regions.[124] Another important mechanism concerns nucleotide excision repair, which can be recruited by the transcription machinery, lowering somatic mutation rates in active genes[122] and other open chromatin regions.[125]
DNA repair and evolution[edit]
The basic processes of DNA repair are highly conserved among both prokaryotes and eukaryotes and even among bacteriophages (viruses which infect bacteria); however, more complex organisms with more complex genomes have correspondingly more complex repair mechanisms.[126] The ability of a large number of protein structural motifs to catalyze relevant chemical reactions has played a significant role in the elaboration of repair mechanisms during evolution. For an extremely detailed review of hypotheses relating to the evolution of DNA repair, see.[127]
The fossil record indicates that single-cell life began to proliferate on the planet at some point during the Precambrian period, although exactly when recognizably modern life first emerged is unclear. Nucleic acids became the sole and universal means of encoding genetic information, requiring DNA repair mechanisms that in their basic form have been inherited by all extant life forms from their common ancestor. The emergence of Earth's oxygen-rich atmosphere (known as the "oxygen catastrophe") due to photosynthetic organisms, as well as the presence of potentially damaging free radicals in the cell due to oxidative phosphorylation, necessitated the evolution of DNA repair mechanisms that act specifically to counter the types of damage induced by oxidative stress.
Rate of evolutionary change[edit]
On some occasions, DNA damage is not repaired, or is repaired by an error-prone mechanism that results in a change from the original sequence. When this occurs, mutations may propagate into the genomes of the cell's progeny. Should such an event occur in a germ line cell that will eventually produce a gamete, the mutation has the potential to be passed on to the organism's offspring. The rate of evolution in a particular species (or, in a particular gene) is a function of the rate of mutation. As a consequence, the rate and accuracy of DNA repair mechanisms have an influence over the process of evolutionary change.[128] DNA damage protection and repair does not influence the rate of adaptation by gene regulation and by recombination and selection of alleles. On the other hand, DNA damage repair and protection does influence the rate of accumulation of irreparable, advantageous, code expanding, inheritable mutations, and slows down the evolutionary mechanism for expansion of the genome of organisms with new functionalities. The tension between evolvability and mutation repair and protection needs further investigation.
DNA repair technology[edit]
A technology named clustered regularly interspaced short palindromic repeat shortened to CRISPR-Cas9 was discovered in 2012. The new technology allows anyone with molecular biology training to alter the genes of any species with precision.[129]
It is a cheaper, more efficient and precise than other technologies. With the help of CRISPR–Cas9,parts of a genome can be edited by scientists by removing or adding or altering parts in a DNA sequence.
See also[edit]
Molecular and Cellular Biology portal
Accelerated aging disease
Aging DNA
Cell cycle
DNA damage (naturally occurring)
DNA damage theory of aging
DNA replication
Direct DNA damage
Gene therapy
Human mitochondrial genetics
Indirect DNA damage
Life extension
Progeria
Senescence
SiDNA
The scientific journal DNA Repair under Mutation Research
References[edit]
^ Jump up to: a b Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, Zipursky SL, Darnell J (2004). Molecular Biology of the Cell (5th ed.). New York: WH Freeman. p. 963.
^ Jump up to: a b Acharya, PV (1971). "The isolation and partial characterization of age-correlated oligo-deoxyribo-ribonucleotides with covalently linked aspartyl-glutamyl polypeptides". Johns Hopkins medical journal. Supplement (1): 254–60. PMID 5055816.
^ Jump up to: a b Bjorksten, J; Acharya, PVN; Ashman, S; Wetlaufer, DB (1971). "Gerogenic fractions in the tritiated rat". Journal of the American Geriatrics Society. 19 (7): 561–74. doi:10.1111/j.1532-5415.1971.tb02577.x. PMID 5106728.
Jump up ^ Browner, WS; Kahn, AJ; Ziv, E; Reiner, AP; Oshima, J; Cawthon, RM; Hsueh, WC; Cummings, SR. (2004). "The genetics of human longevity". Am J Med. 117 (11): 851–60. doi:10.1016/j.amjmed.2004.06.033. PMID 15589490.
Jump up ^ Broad, William J. (7 October 2015). "Nobel Prize in Chemistry Awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for DNA Studies". New York Times. Retrieved 7 October 2015.
Jump up ^ Staff (7 October 2015). "The Nobel Prize in Chemistry 2015 – DNA repair – providing chemical stability for life" (PDF). Nobel Prize. Retrieved 7 October 2015.
Jump up ^ Roulston A, Marcellus RC, Branton PE (1999). "Viruses and apoptosis". Annu. Rev. Microbiol. 53: 577–628. doi:10.1146/annurev.micro.53.1.577. PMID 10547702.
Jump up ^ Madigan MT, Martino JM (2006). Brock Biology of Microorganisms (11th ed.). Pearson. p. 136. ISBN 0-13-196893-9.
Jump up ^ Ohta, Toshihiro; Shin-ichi, Tokishita; Mochizuki, Kayo; Kawase, Jun; Sakahira, Masahide; Yamagata, Hideo (2006). "UV Sensitivity and Mutagenesis of the Extremely Thermophilic Eubacterium Thermus thermophilus HB27". Genes and Environment. 28 (2): 56–61. doi:10.3123/jemsge.28.56. [permanent dead link]
Jump up ^ Braig, M; Schmitt, CA. (2006). "Oncogene-induced senescence: putting the brakes on tumor development". Cancer Res. 66 (6): 2881–2884. doi:10.1158/0008-5472.CAN-05-4006. PMID 16540631.
Jump up ^ Lynch, MD. (2006). "How does cellular senescence prevent cancer?". DNA Cell Biol. 25 (2): 69–78. doi:10.1089/dna.2006.25.69. PMID 16460230.
Jump up ^ Campisi J, d'Adda di Fagagna F (2007). "Cellular senescence: when bad things happen to good cells". Rev Mol Cell Biol. 8 (9): 729–40. doi:10.1038/nrm2233. PMID 17667954.
^ Jump up to: a b c Best, Benjamin P (2009). "Nuclear DNA damage as a direct cause of aging" (PDF). Rejuvenation Research. 12 (3): 199–208. doi:10.1089/rej.2009.0847. PMID 19594328.
Jump up ^ Sancar, A. (2003). "Structure and function of DNA photolyase and cryptochrome blue-light photoreceptors". Chem Rev. 103 (6): 2203–37. doi:10.1021/cr0204348. PMID 12797829.
Jump up ^ Michael Lynch, José Ignacio Lucas-Lledó; Lynch, M. (19 February 2009). "Evolution of Mutation Rates: Phylogenomic Analysis of the Photolyase/Cryptochrome Family". Molecular Biology and Evolution. 26 (5): 1143–1153. doi:10.1093/molbev/msp029. PMC 2668831  . PMID 19228922.
^ Jump up to: a b c Watson JD, Baker TA, Bell SP, Gann A, Levine M, Losick R (2004). Molecular Biology of the Gene (5th ed.). Pearson Benjamin Cummings; CSHL Press. Ch. 9, 10. OCLC 936762772.
Jump up ^ Volkert MR (1988). "Adaptive response of Escherichia coli to alkylation damage". Environmental and Molecular Mutagenesis. 11 (2): 241–55. doi:10.1002/em.2850110210. PMID 3278898.
^ Jump up to: a b c Willey, J; Sherwood, L; Woolverton, C (2014). Prescott’s Microbiology. New York, New York: McGraw Hill. p. 381. ISBN 978-0-07-3402-40-6.
^ Jump up to: a b c d Reardon, J; Sancar, A (2006). "Purification and Characterization of Escherichia coli and Human Nucleotide Excision Repair Enzyme Systems". Methods in Enzymology. 408: 189–213. doi:10.1016/S0076-6879(06)08012-8. PMID 16793370.
Jump up ^ Berg, M; Tymoczko, J; Stryer, L (2012). Biochemistry 7th edition. New York: W.H. Freeman and Company. p. 840. ISBN 9781429229364.
Jump up ^ Liang L, Deng L, Chen Y, Li GC, Shao C, Tischfield JA (2005). "Modulation of DNA end joining by nuclear proteins". J. Biol. Chem. 280 (36): 31442–9. doi:10.1074/jbc.M503776200. PMID 16012167.
^ Jump up to: a b Truong LN, Li Y, Shi LZ, Hwang PY, He J, Wang H, Razavian N, Berns MW, Wu X (2013). "Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells". Proc. Natl. Acad. Sci. U.S.A. 110 (19): 7720–5. doi:10.1073/pnas.1213431110. PMC 3651503  . PMID 23610439.
Jump up ^ Wilson TE, Grawunder U, Lieber MR (July 1997). "Yeast DNA ligase IV mediates non-homologous DNA end joining". Nature. 388 (6641): 495–8. doi:10.1038/41365. PMID 9242411.
Jump up ^ Moore JK, Haber JE (May 1996). "Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae". Molecular and Cellular Biology. 16 (5): 2164–73. PMC 231204  . PMID 8628283.
Jump up ^ Boulton SJ, Jackson SP (September 1996). "Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways". The EMBO Journal. 15 (18): 5093–103. PMC 452249  . PMID 8890183.
Jump up ^ Wilson TE, Lieber MR (August 1999). "Efficient processing of DNA ends during yeast nonhomologous end joining. Evidence for a DNA polymerase beta (Pol4)-dependent pathway". The Journal of Biological Chemistry. 274 (33): 23599–609. doi:10.1074/jbc.274.33.23599. PMID 10438542.
Jump up ^ Budman J, Chu G (February 2005). "Processing of DNA for nonhomologous end-joining by cell-free extract". The EMBO Journal. 24 (4): 849–60. doi:10.1038/sj.emboj.7600563. PMC 549622  . PMID 15692565.
Jump up ^ Wang H, Perrault AR, Takeda Y, Qin W, Wang H, Iliakis G (September 2003). "Biochemical evidence for Ku-independent backup pathways of NHEJ". Nucleic Acids Research. 31 (18): 5377–88. doi:10.1093/nar/gkg728. PMC 203313  . PMID 12954774.
Jump up ^ Jung D, Alt FW (January 2004). "Unraveling V(D)J recombination; insights into gene regulation". Cell. 116 (2): 299–311. doi:10.1016/S0092-8674(04)00039-X. PMID 14744439.
Jump up ^ Sharma S, Javadekar SM, Pandey M, Srivastava M, Kumari R, Raghavan SC (2015). "Homology and enzymatic requirements of microhomology-dependent alternative end joining". Cell Death Dis. 6: e1697. doi:10.1038/cddis.2015.58. PMC 4385936  . PMID 25789972.
Jump up ^ Decottignies A (2013). "Alternative end-joining mechanisms: a historical perspective". Front Genet. 4: 48. doi:10.3389/fgene.2013.00048. PMC 3613618  . PMID 23565119.
Jump up ^ Zahradka K, Slade D, Bailone A, et al. (October 2006). "Reassembly of shattered chromosomes in Deinococcus radiodurans". Nature. 443 (7111): 569–73. doi:10.1038/nature05160. PMID 17006450.
Jump up ^ Waters LS, Minesinger BK, Wiltrout ME, D'Souza S, Woodruff RV, Walker GC (March 2009). "Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance". Microbiol. Mol. Biol. Rev. 73 (1): 134–54. doi:10.1128/MMBR.00034-08. PMC 2650891  . PMID 19258535.
Jump up ^ LC Colis; P Raychaudhury; AK Basu (2008). "Mutational specificity of gamma-radiation-induced guanine-thymine and thymine-guanine intrastrand cross-links in mammalian cells and translesion synthesis past the guanine-thymine lesion by human DNA polymerase eta". Biochemistry. 47 (6): 8070–8079. doi:10.1021/bi800529f. PMC 2646719  . PMID 18616294.
Jump up ^ P Raychaudhury; Basu, Ashis K. (2011). "Genetic requirement for mutagenesis of the G[8,5-Me]T cross-link in Escherichia coli: DNA polymerases IV and V compete for error-prone bypass". Biochemistry. 50 (12): 2330–2338. doi:10.1021/bi102064z. PMC 3062377  . PMID 21302943.
Jump up ^ "Translesion Synthesis". Research.chem.psu.edu. Archived from the original on 2012-03-10. Retrieved 2012-08-14.
Jump up ^ Wang, Z (2001). "Translesion synthesis by the UmuC family of DNA polymerases". Mutat. Res. 486 (2): 59–70. doi:10.1016/S0921-8777(01)00089-1. PMID 11425512.
^ Jump up to: a b c Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. (2006). DNA Repair and Mutagenesis, part 3. ASM Press. 2nd ed.
Jump up ^ Liu B, Yip RK, Zhou Z (2012). "Chromatin remodeling, DNA damage repair and aging". Curr. Genomics. 13 (7): 533–47. doi:10.2174/138920212803251373. PMC 3468886  . PMID 23633913.
^ Jump up to: a b c Sellou H, Lebeaupin T, Chapuis C, Smith R, Hegele A, Singh HR, Kozlowski M, Bultmann S, Ladurner AG, Timinszky G, Huet S (2016). "The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage". Mol. Biol. Cell. 27 (24): 3791–3799. doi:10.1091/mbc.E16-05-0269. PMC 5170603  . PMID 27733626.
^ Jump up to: a b Van Meter M, Simon M, Tombline G, May A, Morello TD, Hubbard BP, Bredbenner K, Park R, Sinclair DA, Bohr VA, Gorbunova V, Seluanov A (2016). "JNK Phosphorylates SIRT6 to Stimulate DNA Double-Strand Break Repair in Response to Oxidative Stress by Recruiting PARP1 to DNA Breaks". Cell Rep. 16 (10): 2641–50. doi:10.1016/j.celrep.2016.08.006. PMC 5089070  . PMID 27568560.
^ Jump up to: a b Haince JF, McDonald D, Rodrigue A, Déry U, Masson JY, Hendzel MJ, Poirier GG (2008). "PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites". J. Biol. Chem. 283 (2): 1197–208. doi:10.1074/jbc.M706734200. PMID 18025084.
^ Jump up to: a b c Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998). "DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139". J. Biol. Chem. 273 (10): 5858–68. doi:10.1074/jbc.273.10.5858. PMID 9488723.
Jump up ^ Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J (2007). "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins". Cell. 131 (5): 887–900. doi:10.1016/j.cell.2007.09.040. PMID 18001824.
Jump up ^ Luijsterburg MS, Acs K, Ackermann L, Wiegant WW, Bekker-Jensen S, Larsen DH, Khanna KK, van Attikum H, Mailand N, Dantuma NP (2012). "A new non-catalytic role for ubiquitin ligase RNF8 in unfolding higher-order chromatin structure". EMBO J. 31 (11): 2511–27. doi:10.1038/emboj.2012.104. PMC 3365417  . PMID 22531782.
^ Jump up to: a b Luijsterburg MS, Goedhart J, Moser J, Kool H, Geverts B, Houtsmuller AB, Mullenders LH, Vermeulen W, van Driel R (August 2007). "Dynamic in vivo interaction of DDB2 E3 ubiquitin ligase with UV-damaged DNA is independent of damage-recognition protein XPC". Journal of Cell Science. 120 (Pt 15): 2706–16. doi:10.1242/jcs.008367. PMID 17635991.
^ Jump up to: a b Pines A, Vrouwe MG, Marteijn JA, Typas D, Luijsterburg MS, Cansoy M, Hensbergen P, Deelder A, de Groot A, Matsumoto S, Sugasawa K, Thoma N, Vermeulen W, Vrieling H, Mullenders L (October 2012). "PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1". The Journal of Cell Biology. 199 (2): 235–49. doi:10.1083/jcb.201112132. PMC 3471223  . PMID 23045548.
Jump up ^ Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP (2006). "ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks". Nat. Cell Biol. 8 (1): 37–45. doi:10.1038/ncb1337. PMID 16327781.
Jump up ^ Bakkenist CJ, Kastan MB (January 2003). "DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation". Nature. 421 (6922): 499–506. doi:10.1038/nature01368. PMID 12556884.
Jump up ^ Wei, Qingyi; Lei Li; David Chen (2007). DNA Repair, Genetic Instability, and Cancer. World Scientific. ISBN 981-270-014-5. [page needed]
Jump up ^ Schonthal, Axel H. (2004). Checkpoint Controls and Cancer. Humana Press. ISBN 1-58829-500-1. [page needed]
Jump up ^ Gartel AL, Tyner AL (June 2002). "The role of the cyclin-dependent kinase inhibitor p21 in apoptosis". Molecular Cancer Therapeutics. 1 (8): 639–49. PMID 12479224.
Jump up ^ Janion, C. (2001). "Some aspects of the SOS response system-a critical survey". Acta Biochim Pol. 48 (3): 599–610. PMID 11833768.
^ Jump up to: a b Erill, I; Campoy, S; Barbé, J (2007). "Aeons of distress: an evolutionary perspective on the bacterial SOS response". FEMS Microbiol Rev. 31 (6): 637–656. doi:10.1111/j.1574-6976.2007.00082.x. PMID 17883408.
Jump up ^ Schlacher, K; Pham, P; Cox, MM; Goodman, MF. (2006). "Roles of DNA Polymerase V and RecA Protein in SOS Damage-Induced Mutation". Chem. Rev. 106 (2): 406–419. doi:10.1021/cr0404951. PMID 16464012.
Jump up ^ Fry, RC; Begley, TJ; Samson, LD (2004). "Genome-wide responses to DNA-damaging agents". Annu Rev Microbiol. 59: 357–77. doi:10.1146/annurev.micro.59.031805.133658. PMID 16153173.
Jump up ^ Espejel, S; Martin, M; Klatt, P; Martin-Caballero, J; Flores, JM; Blasco, MA. (2004). "Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice". EMBO Rep. 5 (5): 503–9. doi:10.1038/sj.embor.7400127. PMC 1299048  . PMID 15105825.
Jump up ^ De Boer, J; Andressoo, JO; De Wit, J; Huijmans, J; Beems, RB; Van Steeg, H; Weeda, G; Van Der Horst, GT; et al. (2002). "Premature aging in mice deficient in DNA repair and transcription". Science. 296 (5571): 1276–9. doi:10.1126/science.1070174. PMID 11950998.
Jump up ^ Dolle, ME; Busuttil, RA; Garcia, AM; Wijnhoven, S; van Drunen, E; Niedernhofer, LJ; der Horst, G; Hoeijmakers, JH; et al. (2006). "Increased genomic instability is not a prerequisite for shortened life span in DNA repair deficient mice". Mutation Research. 596 (1–2): 22–35. doi:10.1016/j.mrfmmm.2005.11.008. PMID 16472827. CS1 maint: Explicit use of et al. (link)
Jump up ^ Kobayashi, Y; Narumi, I; Satoh, K; Funayama, T; Kikuchi, M; Kitayama, S; Watanabe, H. (2004). "Radiation response mechanisms of the extremely radioresistant bacterium Deinococcus radiodurans". Biol Sci Space. 18 (3): 134–5. PMID 15858357.
Jump up ^ Spindler, SR. (2005). "Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction". Mech Ageing Dev. 126 (9): 960–6. doi:10.1016/j.mad.2005.03.016. PMID 15927235.
Jump up ^ Halicka HD, Zhao H, Li J, Lee YS, Hsieh TC, Wu JM, Darzynkiewicz Z. (2012) Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling. Aging (Albany NY). Dec; 4(12):952-65. PMID 23363784.
Jump up ^ Tissenbaum, HA; Guarente, L. (2001). "Increased dosage of a sir-2 gene extends life span in Caenorhabditis elegans". Nature. 410 (6825): 227–30. doi:10.1038/35065638. PMID 11242085.
Jump up ^ Cohen, HY; Miller, C; Bitterman, KJ; Wall, NR; Hekking, B; Kessler, B; Howitz, KT; Gorospe, M; et al. (2004). "Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase". Science. 305 (5682): 390–2. doi:10.1126/science.1099196. PMID 15205477. CS1 maint: Explicit use of et al. (link)
Jump up ^ Cabelof, DC; Yanamadala, S; Raffoul, JJ; Guo, Z; Soofi, A; Heydari, AR. (2003). "Caloric restriction promotes genomic stability by induction of base excision repair and reversal of its age-related decline". DNA Repair (Amst.). 2 (3): 295–307. doi:10.1016/S1568-7864(02)00219-7. PMID 12547392.
Jump up ^ Stuart, JA; Karahalil, B; Hogue, BA; Souza-Pinto, NC; Bohr, VA. (2004). "Mitochondrial and nuclear DNA base excision repair are affected differently by caloric restriction". FASEB J. 18 (3): 595–7. doi:10.1096/fj.03-0890fje. PMID 14734635.
Jump up ^ Walker, DW; McColl, G; Jenkins, NL; Harris, J; Lithgow, GJ. (2000). "Evolution of lifespan in C. elegans". Nature. 405 (6784): 296–7. doi:10.1038/35012693. PMID 10830948.
Jump up ^ Johnson, George (28 December 2010). "Unearthing Prehistoric Tumors, and Debate". The New York Times. If we lived long enough, sooner or later we all would get cancer.
Jump up ^ Alberts, B; Johnson A; Lewis J; et al. (2002). "The Preventable Causes of Cancer". Molecular biology of the cell (4th ed.). New York: Garland Science. ISBN 0-8153-4072-9. A certain irreducible background incidence of cancer is to be expected regardless of circumstances: mutations can never be absolutely avoided, because they are an inescapable consequence of fundamental limitations on the accuracy of DNA replication, as discussed in Chapter 5. If a human could live long enough, it is inevitable that at least one of his or her cells would eventually accumulate a set of mutations sufficient for cancer to develop.
Jump up ^ Gavande NS, VanderVere-Carozza PS, Hinshaw HD, Jalal SI, Sears CR, Pawelczak KS, Turchi JJ (April 2016). "DNA repair targeted therapy: The past or future of cancer treatment?". Pharmacol Ther. 160: 65–83. doi:10.1016/j.pharmthera.2016.02.003. PMC 4811676  . PMID 26896565.
Jump up ^ Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (April 2005). "Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase". Nature. 434 (7035): 913–7. doi:10.1038/nature03443. PMID 15829966.
Jump up ^ Goldstein M, Kastan MB (2015). "The DNA damage response: implications for tumor responses to radiation and chemotherapy". Annu Rev Med. 66: 129–43. doi:10.1146/annurev-med-081313-121208. PMID 25423595.
^ Jump up to: a b Jeggo PA, Pearl LH, Carr AM (Jan 2016). "DNA repair, genome stability and cancer: a historical perspective". Nat Rev Cancer. 16 (1): 35–42. doi:10.1038/nrc.2015.4. PMID 26667849.
Jump up ^ Bartkova J, Horejsi Z, et al. (April 2005). "DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis". Nature. 434 (7035): 864–70. doi:10.1038/nature03482. PMID 15829956.
^ Jump up to: a b Bartkova J, Rezaei N, et al. (Nov 2006). "Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints". Nature. 444 (7119): 633–7. doi:10.1038/nature05268. PMID 17136093.
Jump up ^ Gaillard H, Garcia-Muse T, Aguilera A (May 2015). "Replication stress and cancer". Nat Rev Cancer. 15 (5): 276–89. doi:10.1038/nrc3916. PMID 25907220.
Jump up ^ Halazonetis TD, Gorgoulis VG, Bartek J (Mar 2008). "An oncogene-induced DNA damage model for cancer development". Science. 319: 1352–5. doi:10.1126/science.1140735. PMID 18323444.
Jump up ^ de Boer J, Heoijmakers JH (Mar 2000). "Nucleotide excision repair and human syndromes". Carcinogenesis. 21 (3): 453–60. doi:10.1093/carcin/21.3.453. PMID 10688865.
Jump up ^ Broustas CG, Lieberman HB (Feb 2014). "DNA damage response genes and the development of cancer metastasis". Radiat Res. 181 (2): 111–30. doi:10.1667/RR13515.1. PMC 4064942  . PMID 24397478.
Jump up ^ Zhang P, Wang J, Gao W, Yuan BZ, Rogers J, Reed E (May 2004). "CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer". Mol Cancer. 3 (4): 3–14. doi:10.1186/1476-4598-3-14. PMC 419366  . PMID 15125777.
Jump up ^ Baylin SB; Ohm, Joyce E. (February 2006). "Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?". Nat. Rev. Cancer. 6 (2): 107–16. doi:10.1038/nrc1799. PMID 16491070.
Jump up ^ Kanwal R, Gupta S (April 2012). "Epigenetic modifications in cancer". Clinical Genetics. 81 (4): 303–11. doi:10.1111/j.1399-0004.2011.01809.x. PMC 3590802  . PMID 22082348.
Jump up ^ Baldassarre G, Battista S, Belletti B, et al. (April 2003). "Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma". Molecular and Cellular Biology. 23 (7): 2225–38. doi:10.1128/MCB.23.7.2225-2238.2003. PMC 150734  . PMID 12640109.
Jump up ^ Jacinto FV, Esteller M; Esteller, M. (July 2007). "Mutator pathways unleashed by epigenetic silencing in human cancer". Mutagenesis. 22 (4): 247–53. doi:10.1093/mutage/gem009. PMID 17412712.
Jump up ^ Lahtz C; Pfeifer, G. P. (February 2011). "Epigenetic changes of DNA repair genes in cancer". J Mol Cell Biol. 3 (1): 51–8. doi:10.1093/jmcb/mjq053. PMC 3030973  . PMID 21278452. http://jmcb.oxfordjournals.org/content/3/1/51.long
Jump up ^ Bernstein C, Nfonsam V, Prasad AR, Bernstein H (March 2013). "Epigenetic field defects in progression to cancer". World J Gastrointest Oncol. 5 (3): 43–9. doi:10.4251/wjgo.v5.i3.43. PMC 3648662  . PMID 23671730.
Jump up ^ Bernstein C, Prasad AR, Nfonsam V, Bernstein H. (2013). "Chapter 16: DNA Damage, DNA Repair and Cancer", New Research Directions in DNA Repair, Prof. Clark Chen (Ed.), ISBN 978-953-51-1114-6, InTech.
Jump up ^ Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (April 1997). "Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2". Proceedings of the National Academy of Sciences of the United States of America. 94 (7): 3122–7. doi:10.1073/pnas.94.7.3122. PMC 20332  . PMID 9096356.
Jump up ^ Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). "Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6". Carcinogenesis. 27 (12): 2402–8. doi:10.1093/carcin/bgl079. PMC 2612936  . PMID 16728433.
Jump up ^ Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A (March 2002). "Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation". EMBO Reports. 3 (3): 255–60. doi:10.1093/embo-reports/kvf037. PMC 1084010  . PMID 11850397.
Jump up ^ German J (March 1969). "Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients". American Journal of Human Genetics. 21 (2): 196–227. PMC 1706430  . PMID 5770175.
Jump up ^ O'Hagan HM, Mohammad HP, Baylin SB (2008). "Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island". PLoS Genetics. 4 (8): e1000155. doi:10.1371/journal.pgen.1000155. PMC 2491723  . PMID 18704159.
Jump up ^ Cuozzo C, Porcellini A, Angrisano T, et al. (July 2007). "DNA damage, homology-directed repair, and DNA methylation". PLoS Genetics. 3 (7): e110. doi:10.1371/journal.pgen.0030110. PMC 1913100  . PMID 17616978.
Jump up ^ Malkin D (April 2011). "Li-fraumeni syndrome". Genes & Cancer. 2 (4): 475–84. doi:10.1177/1947601911413466. PMC 3135649  . PMID 21779515.
Jump up ^ Fearon ER (November 1997). "Human cancer syndromes: clues to the origin and nature of cancer". Science. 278 (5340): 1043–50. doi:10.1126/science.278.5340.1043. PMID 9353177.
Jump up ^ Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). "O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions". Gut. 54 (6): 797–802. doi:10.1136/gut.2004.059535. PMC 1774551  . PMID 15888787.
Jump up ^ Shen L, Kondo Y, Rosner GL, et al. (September 2005). "MGMT promoter methylation and field defect in sporadic colorectal cancer". Journal of the National Cancer Institute. 97 (18): 1330–8. doi:10.1093/jnci/dji275. PMID 16174854.
Jump up ^ Psofaki V, Kalogera C, Tzambouras N, et al. (July 2010). "Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas". World Journal of Gastroenterology. 16 (28): 3553–60. doi:10.3748/wjg.v16.i28.3553. PMC 2909555  . PMID 20653064.
Jump up ^ Lee KH, Lee JS, Nam JH, et al. (October 2011). "Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence". Langenbeck's Archives of Surgery. 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID 21706233.
Jump up ^ Amatu A, Sartore-Bianchi A, Moutinho C, et al. (April 2013). "Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer". Clinical Cancer Research. 19 (8): 2265–72. doi:10.1158/1078-0432.CCR-12-3518. PMID 23422094.
Jump up ^ Mokarram P, Zamani M, Kavousipour S, et al. (May 2013). "Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer". Molecular Biology Reports. 40 (5): 3851–7. doi:10.1007/s11033-012-2465-3. PMID 23271133.
Jump up ^ Truninger K, Menigatti M, Luz J, et al. (May 2005). "Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer". Gastroenterology. 128 (5): 1160–71. doi:10.1053/j.gastro.2005.01.056. PMID 15887099.
Jump up ^ Valeri N, Gasparini P, Fabbri M, et al. (April 2010). "Modulation of mismatch repair and genomic stability by miR-155". Proceedings of the National Academy of Sciences of the United States of America. 107 (15): 6982–7. doi:10.1073/pnas.1002472107. PMC 2872463  . PMID 20351277.
^ Jump up to: a b Carol Bernstein and Harris Bernstein (2015). Epigenetic Reduction of DNA Repair in Progression to Cancer, Advances in DNA Repair, Prof. Clark Chen (Ed.), ISBN 978-953-51-2209-8, InTech, Available from: http://www.intechopen.com/books/advances-in-dna-repair/epigenetic-reduction-of-dna-repair-in-progression-to-cancer
Jump up ^ Facista A, Nguyen H, Lewis C, et al. (2012). "Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer". Genome Integrity. 3 (1): 3. doi:10.1186/2041-9414-3-3. PMC 3351028  . PMID 22494821.
Jump up ^ Human DNA Repair Genes, 15 April 2014, MD Anderson Cancer Center, University of Texas
Jump up ^ Xinrong Chen and Tao Chen (2011). "Chapter 18: Roles of MicroRNA in DNA Damage and Repair", DNA Repair, Inna Kruman (ed.), ISBN 978-953-307-697-3, InTech.
Jump up ^ Krishnan K, Steptoe AL, Martin HC, et al. (February 2013). "MicroRNA-182-5p targets a network of genes involved in DNA repair". RNA. 19 (2): 230–42. doi:10.1261/rna.034926.112. PMC 3543090  . PMID 23249749.
Jump up ^ Chaisaingmongkol J, Popanda O, Warta R, et al. (December 2012). "Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma". Oncogene. 31 (49): 5108–16. doi:10.1038/onc.2011.660. PMID 22286769.
Jump up ^ Liang L, Deng L, Chen Y, Li GC, Shao C, Tischfield JA (2005). "Modulation of DNA end joining by nuclear proteins". J. Biol. Chem. 280 (36): 31442–9. doi:10.1074/jbc.M503776200. PMID 16012167.
Jump up ^ Singh P, Yang M, Dai H, Yu D, Huang Q, Tan W, Kernstine KH, Lin D, Shen B (2008). "Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers". Mol. Cancer Res. 6 (11): 1710–7. doi:10.1158/1541-7786.MCR-08-0269. PMC 2948671  . PMID 19010819.
Jump up ^ Lam JS, Seligson DB, Yu H, Li A, Eeva M, Pantuck AJ, Zeng G, Horvath S, Belldegrun AS (2006). "Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score". BJU Int. 98 (2): 445–51. doi:10.1111/j.1464-410X.2006.06224.x. PMID 16879693.
Jump up ^ Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Yoo HS, Kim YS, Kim JG, Kim NS (2005). "Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells". Clin. Cancer Res. 11 (2 Pt 1): 473–82. PMID 15701830.
Jump up ^ Wang K, Xie C, Chen D (2014). "Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis". Int. J. Mol. Med. 33 (5): 1268–74. doi:10.3892/ijmm.2014.1682. PMID 24590400.
Jump up ^ Krause A, Combaret V, Iacono I, Lacroix B, Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B, Puisieux A (2005). "Genome-wide analysis of gene expression in neuroblastomas detected by mass screening". Cancer Lett. 225 (1): 111–20. doi:10.1016/j.canlet.2004.10.035. PMID 15922863.
Jump up ^ Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M (2003). "Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays". Am. J. Pathol. 162 (4): 1151–62. doi:10.1016/S0002-9440(10)63911-9. PMC 1851213  . PMID 12651607.
Jump up ^ Sato M, Girard L, Sekine I, Sunaga N, Ramirez RD, Kamibayashi C, Minna JD (2003). "Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer". Oncogene. 22 (46): 7243–6. doi:10.1038/sj.onc.1206977. PMID 14562054.
Jump up ^ Bi FF, Li D, Yang Q (2013). "Hypomethylation of ETS transcription factor binding sites and upregulation of PARP1 expression in endometrial cancer". Biomed Res Int. 2013: 946268. doi:10.1155/2013/946268. PMC 3666359  . PMID 23762867.
Jump up ^ Li D, Bi FF, Cao JM, Cao C, Li CY, Liu B, Yang Q (2014). "Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer". Oncotarget. 5 (1): 291–7. doi:10.18632/oncotarget.1549. PMC 3960209  . PMID 24448423.
Jump up ^ Bi FF, Li D, Yang Q (2013). "Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer". BMC Cancer. 13: 90. doi:10.1186/1471-2407-13-90. PMC 3599366  . PMID 23442605.
Jump up ^ Supek, Fran; Lehner, Ben (2015-05-07). "Differential DNA mismatch repair underlies mutation rate variation across the human genome". Nature. 521 (7550): 81–84. doi:10.1038/nature14173. ISSN 0028-0836. PMC 4425546  . PMID 25707793.
^ Jump up to: a b Zheng, Christina L.; Wang, Nicholas J.; Chung, Jongsuk; Moslehi, Homayoun; Sanborn, J. Zachary; Hur, Joseph S.; Collisson, Eric A.; Vemula, Swapna S.; Naujokas, Agne (2014-11-20). "Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes". Cell reports. 9 (4): 1228–1234. doi:10.1016/j.celrep.2014.10.031. ISSN 2211-1247. PMC 4254608  . PMID 25456125.
Jump up ^ Li, Feng; Mao, Guogen; Tong, Dan; Huang, Jian; Gu, Liya; Yang, Wei; Li, Guo-Min (2013-04-25). "The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα". Cell. 153 (3): 590–600. doi:10.1016/j.cell.2013.03.025. ISSN 1097-4172. PMC 3641580  . PMID 23622243.
Jump up ^ Supek, Fran; Lehner, Ben (2017-07-27). "Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes". Cell. 170 (3): 534–547.e23. doi:10.1016/j.cell.2017.07.003. ISSN 1097-4172. PMID 28753428.
Jump up ^ Polak, Paz; Lawrence, Michael S.; Haugen, Eric; Stoletzki, Nina; Stojanov, Petar; Thurman, Robert E; Garraway, Levi A.; Mirkin, Sergei; Getz, Gad (January 2014). "Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair". Nature Biotechnology. 32 (1): 71–75. doi:10.1038/nbt.2778. ISSN 1087-0156. PMC 4116484  . PMID 24336318.
Jump up ^ Cromie, GA; Connelly, JC; Leach, DR (2001). "Recombination at double-strand breaks and DNA ends: conserved mechanisms from phage to humans". Mol. Cell. 8 (6): 1163–74. doi:10.1016/S1097-2765(01)00419-1. PMID 11779493.
Jump up ^ O'Brien, PJ. (2006). "Catalytic promiscuity and the divergent evolution of DNA repair enzymes". Chem Rev. 106 (2): 720–52. doi:10.1021/cr040481v. PMID 16464022.
Jump up ^ Maresca, B; Schwartz, JH (2006). "Sudden origins: a general mechanism of evolution based on stress protein concentration and rapid environmental change". Anat Rec B New Anat. 289 (1): 38–46. doi:10.1002/ar.b.20089. PMID 16437551.
Jump up ^ "CRISPR gene-editing tool has scientists thrilled — but nervous" CBC news. Author Kelly Crowe. November 30, 2015.
External links[edit]
Library resources about
DNA repair
Online books
Resources in your library
Resources in other libraries
Listen to this article (info/dl)

This audio file was created from a revision of the article "DNA repair" dated 2005-06-17, and does not reflect subsequent edits to the article. (Audio help)
More spoken articles
Roswell Park Cancer Institute DNA Repair Lectures
A comprehensive list of Human DNA Repair Genes
3D structures of some DNA repair enzymes
Human DNA repair diseases
DNA repair special interest group
DNA Repair
DNA Damage and DNA Repair
Segmental Progeria
DNA-damage repair; the good, the bad, and the ugly
[hide]
v
t
e
DNA repair
Excision repair
Base excision repair/AP site
DNA glycosylase
Uracil-DNA glycosylase
Poly ADP ribose polymerase
Nucleotide excision repair/ERCC
XPA
XPB
XPC
XPD/ERCC2
XPE/DDB1
XPF/DDB1
XPG/ERCC5
ERCC1
RPA
RAD23A
RAD23B
Excinuclease
DNA mismatch repair
MLH1
MSH2
Other forms of repair
Transcription-coupled repair
ERCC6
ERCC8
Homology directed repair
Non-homologous end joining
Ku
Microhomology-mediated end joining
Postreplication repair
Photolyase
CRY1
CRY2
Other/ungrouped proteins
Ogt
PcrA
Proliferating Cell Nuclear Antigen
Homologous recombination
RecA/RAD51
Sgs1
Slx4
Regulation
SOS box
SOS response
Other/ungrouped
8-Oxoguanine
Adaptive response
Meiotic recombination checkpoint
RecF pathway
DNA helicase: BLM
WRN
FANC proteins: core protein complex
FANCA
FANCB
FANCC
FANCE
FANCF
FANCG
FANCL
FANCM
FANCD1
FANCD2
FANCI
FANCJ
FANCN
Molecular and cellular biology portal
Retrieved from "https://en.wikipedia.org/w/index.php?title=DNA_repair&oldid=821809345"
Categories:
Cellular processes
Molecular genetics
Mutation
DNA repair
Senescence
Hidden categories:
All articles with dead external links
Articles with dead external links from December 2016
Articles with permanently dead external links
Wikipedia articles needing page number citations from December 2014
CS1 maint: Explicit use of et al.
Wikipedia indefinitely move-protected pages
Pages using div col with deprecated parameters
Spoken articles
Articles with hAudio microformats
Featured articles
Articles containing video clips
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Беларуская
Български
Bosanski
Català
Čeština
Deutsch
Eesti
Español
Euskara
فارسی
Français
Galego
한국어
Հայերեն
Hrvatski
Bahasa Indonesia
Italiano
עברית
ქართული
Кыргызча
Latviešu
Lumbaart
Magyar
Bahasa Melayu
Nederlands
日本語
Norsk
Polski
Português
Русский
සිංහල
Simple English
Slovenčina
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
தமிழ்
ไทย
Türkçe
Українська
Tiếng Việt
中文
Edit links
This page was last edited on 22 January 2018, at 19:32.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

values: mw-page-base noprint

values: mw-head-base noprint

attrs: alt src width height srcset data-file-width data-file-height

values: This is a featured article. Click here for more information.

values: mw-indicator-featured-star mw-indicator

values: mw-indicator-spoken-icon mw-indicator

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

attrs: role class

values:
note
hatnote navigation-not-searchable

attrs: alt src width height class data-file-width data-file-height

attrs: class style

value: b

values: <video id="mwe_player_1" poster="//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Paul_Modrich.webm/854px--Paul_Modrich.webm.jpg" controls="" preload="none" autoplay="" style="width:854px;height:480px" class="kskin" data-durationhint="136.423" data-startoffset="0" data-mwtitle="Paul_Modrich.webm" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.480p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="SD WebM (480P)" data-shorttitle="WebM 480P" data-transcodekey="480p.webm" data-width="854" data-height="480" data-bandwidth="1010752" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.720p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="HD WebM (720P)" data-shorttitle="WebM 720P" data-transcodekey="720p.webm" data-width="1280" data-height="720" data-bandwidth="1313904" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.1080p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Full HD WebM (1080P)" data-shorttitle="WebM 1080P" data-transcodekey="1080p.webm" data-width="1920" data-height="1080" data-bandwidth="3468872" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/a/a1/Paul_Modrich.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Original WebM file, 1,920 × 1,080 (8.35 Mbps)" data-shorttitle="WebM source" data-width="1920" data-height="1080" data-bandwidth="8354514" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.160p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Low bandwidth WebM (160P)" data-shorttitle="WebM 160P" data-transcodekey="160p.webm" data-width="284" data-height="160" data-bandwidth="201608" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.240p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Small WebM (240P)" data-shorttitle="WebM 240P" data-transcodekey="240p.webm" data-width="426" data-height="240" data-bandwidth="306896" data-framerate="50"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/a/a1/Paul_Modrich.webm/Paul_Modrich.webm.360p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="WebM (360P)" data-shorttitle="WebM 360P" data-transcodekey="360p.webm" data-width="640" data-height="360" data-bandwidth="540616" data-framerate="50"/></video>

values:
/wiki/Paul_Modrich
mw-redirect
Paul Modrich

values:
/wiki/Primary_structure
mw-redirect
Primary structure

values:
/wiki/Tertiary_structure
mw-redirect
Tertiary structure

values:
/wiki/Pyrimidine_dimers
mw-redirect
Pyrimidine dimers

values:
/wiki/Cosmic_rays
mw-redirect
Cosmic rays

values:
/wiki/Thermophilic_bacteria
mw-redirect
Thermophilic bacteria

values:
/wiki/Hot_springs
mw-redirect
Hot springs

values:
/wiki/Ring_pucker
mw-redirect
Ring pucker

values: Edit section: Nuclear versus mitochondrial DNA damage

values:
/wiki/Cellular_signaling
mw-redirect
Cellular signaling

attrs: alt src width height class srcset data-file-width data-file-height

values:
/wiki/Excision_repair
mw-redirect
Excision repair

values:
/wiki/Mismatch_repair
mw-redirect
Mismatch repair

values:
/wiki/Replication_fork
mw-redirect
Replication fork

values:
/wiki/Annealing_(biology)
mw-redirect
Annealing (biology)

values:
/wiki/Thymine_dimer
mw-redirect
Thymine dimer

values:
/wiki/Pyrimidine_dimers#Mutagenesis
mw-redirect
Pyrimidine dimers

values: Edit section: Global response to DNA damage

values:
/wiki/Ultraviolet_light
mw-redirect
Ultraviolet light

values:
/wiki/Ataxia_telangiectasia_mutated
mw-redirect
Ataxia telangiectasia mutated

values:
/wiki/Signal_transduction_pathway
mw-redirect
Signal transduction pathway

values:
/wiki/Phosphatidylinositol_3-kinase
mw-redirect
Phosphatidylinositol 3-kinase

values:
/wiki/Cyclin-dependent_kinase_inhibitor
mw-redirect
Cyclin-dependent kinase inhibitor

values: Edit section: The prokaryotic SOS response

values:
/wiki/Transcription_(genetics)
mw-redirect
Transcription (genetics)

values:
/wiki/DNA_helicase
mw-redirect
DNA helicase

values: Edit section: Eukaryotic transcriptional responses to DNA damage

values:
/wiki/Shock_response
mw-redirect
Shock response

values:
/wiki/DNA_damage_checkpoint
mw-redirect
DNA damage checkpoint

values: Edit section: Pathological effects of poor DNA repair

values: Edit section: Longevity and caloric restriction

values:
/wiki/Caloric_restriction
mw-redirect
Caloric restriction

values:
/wiki/Metabolic_rate
mw-redirect
Metabolic rate

values:
/wiki/Metabolic_activity
mw-redirect
Metabolic activity

values: Edit section: Medicine and DNA repair modulation

values: Edit section: Hereditary DNA repair disorders

values:
/wiki/Werner%27s_syndrome
mw-redirect
Werner's syndrome

values:
/wiki/Ataxia_telangiectasia
mw-redirect
Ataxia telangiectasia

values:
/wiki/Accelerated_aging_disease
mw-redirect
Accelerated aging disease

values:
/wiki/Colon_cancer
mw-redirect
Colon cancer

values: Hereditary nonpolyposis colorectal cancer

values: Edit section: DNA repair defects in cancer

values:
/wiki/Li-Fraumeni_syndrome
mw-redirect
Li-Fraumeni syndrome

values: Edit section: Epigenetic DNA repair defects in cancer

values:
/wiki/Histone_modification
mw-redirect
Histone modification

values:
/wiki/DNA_sequence
mw-redirect
DNA sequence

values: Edit section: Frequencies of epimutations in DNA repair genes

values: Edit section: Genome-wide distribution of DNA repair in human somatic cells

values:
/wiki/Conservation_(genetics)
mw-redirect
Conservation (genetics)

values:
/wiki/Fossil_record
mw-redirect
Fossil record

values:
/wiki/Oxygen_catastrophe
mw-redirect
Oxygen catastrophe

values:
/wiki/Free_radical
mw-redirect
Free radical

values: Edit section: Rate of evolutionary change

values: display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle

values: margin:0.5em 0 0.5em 1em;border:solid #aaa 1px

values: -moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5055816

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5106728

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15589490

values:
/wiki/New_York_Times
mw-redirect
New York Times

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10547702

values:
nofollow
external text
//doi.org/10.3123%2Fjemsge.28.56

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16540631

values:
nofollow
external text
//doi.org/10.1089%2Fdna.2006.25.69

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16460230

values:
nofollow
external text
//doi.org/10.1038%2Fnrm2233

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17667954

values:
nofollow
external text
//doi.org/10.1089%2Frej.2009.0847

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19594328

values:
nofollow
external text
//doi.org/10.1021%2Fcr0204348

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12797829

values:
nofollow
external text
//doi.org/10.1093%2Fmolbev%2Fmsp029

attrs: alt src title width height srcset data-file-width data-file-height

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19228922

values:
nofollow
external text
//www.worldcat.org/oclc/936762772

values:
nofollow
external text
//doi.org/10.1002%2Fem.2850110210

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3278898

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16793370

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M503776200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16012167

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.1213431110

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23610439

values:
nofollow
external text
//doi.org/10.1038%2F41365

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9242411

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8628283

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8890183

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.274.33.23599

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10438542

values:
nofollow
external text
//doi.org/10.1038%2Fsj.emboj.7600563

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15692565

values:
nofollow
external text
//doi.org/10.1093%2Fnar%2Fgkg728

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12954774

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14744439

values:
nofollow
external text
//doi.org/10.1038%2Fcddis.2015.58

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25789972

values:
nofollow
external text
//doi.org/10.3389%2Ffgene.2013.00048

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23565119

values:
nofollow
external text
//doi.org/10.1038%2Fnature05160

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17006450

values:
nofollow
external text
//doi.org/10.1128%2FMMBR.00034-08

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19258535

values:
nofollow
external text
//doi.org/10.1021%2Fbi800529f

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18616294

values:
nofollow
external text
//doi.org/10.1021%2Fbi102064z

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21302943

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11425512

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23633913

values:
nofollow
external text
//doi.org/10.1091%2Fmbc.E16-05-0269

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27733626

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27568560

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M706734200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18025084

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.273.10.5858

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9488723

values:
nofollow
external text
//doi.org/10.1016%2Fj.cell.2007.09.040

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18001824

values:
nofollow
external text
//doi.org/10.1038%2Femboj.2012.104

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22531782

values:
nofollow
external text
//doi.org/10.1242%2Fjcs.008367

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17635991

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.201112132

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23045548

values:
nofollow
external text
//doi.org/10.1038%2Fncb1337

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16327781

values:
nofollow
external text
//doi.org/10.1038%2Fnature01368

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12556884

values: This citation requires a reference to the specific page or range of pages in which the material appears. (December 2014)

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12479224

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11833768

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17883408

values:
nofollow
external text
//doi.org/10.1021%2Fcr0404951

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16464012

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16153173

values:
nofollow
external text
//doi.org/10.1038%2Fsj.embor.7400127

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15105825

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1070174

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11950998

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16472827

values: Category:CS1 maint: Explicit use of et al.

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15858357

values:
nofollow
external text
//doi.org/10.1016%2Fj.mad.2005.03.016

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15927235

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23363784

values:
nofollow
external text
//doi.org/10.1038%2F35065638

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11242085

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1099196

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15205477

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12547392

values:
nofollow
external text
//doi.org/10.1096%2Ffj.03-0890fje

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14734635

values:
nofollow
external text
//doi.org/10.1038%2F35012693

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10830948

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26896565

values:
nofollow
external text
//doi.org/10.1038%2Fnature03443

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15829966

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25423595

values:
nofollow
external text
//doi.org/10.1038%2Fnrc.2015.4

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26667849

values:
nofollow
external text
//doi.org/10.1038%2Fnature03482

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15829956

values:
nofollow
external text
//doi.org/10.1038%2Fnature05268

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17136093

values:
nofollow
external text
//doi.org/10.1038%2Fnrc3916

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25907220

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1140735

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18323444

values:
nofollow
external text
//doi.org/10.1093%2Fcarcin%2F21.3.453

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10688865

values:
nofollow
external text
//doi.org/10.1667%2FRR13515.1

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24397478

values:
nofollow
external text
//doi.org/10.1186%2F1476-4598-3-14

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15125777

values:
nofollow
external text
//doi.org/10.1038%2Fnrc1799

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16491070

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22082348

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12640109

values:
nofollow
external text
//doi.org/10.1093%2Fmutage%2Fgem009

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17412712

values:
nofollow
external text
//doi.org/10.1093%2Fjmcb%2Fmjq053

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21278452

values:
nofollow
external text
//doi.org/10.4251%2Fwjgo.v5.i3.43

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23671730

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.94.7.3122

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9096356

values:
nofollow
external text
//doi.org/10.1093%2Fcarcin%2Fbgl079

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16728433

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11850397

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5770175

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18704159

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17616978

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21779515

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9353177

values:
nofollow
external text
//doi.org/10.1136%2Fgut.2004.059535

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15888787

values:
nofollow
external text
//doi.org/10.1093%2Fjnci%2Fdji275

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16174854

values:
nofollow
external text
//doi.org/10.3748%2Fwjg.v16.i28.3553

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20653064

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21706233

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23422094

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23271133

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15887099

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.1002472107

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20351277

values:
nofollow
external text
//doi.org/10.1186%2F2041-9414-3-3

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22494821

values:
nofollow
external text
//doi.org/10.1261%2Frna.034926.112

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23249749

values:
nofollow
external text
//doi.org/10.1038%2Fonc.2011.660

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22286769

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19010819

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16879693

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15701830

values:
nofollow
external text
//doi.org/10.3892%2Fijmm.2014.1682

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24590400

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15922863

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12651607

values:
nofollow
external text
//doi.org/10.1038%2Fsj.onc.1206977

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14562054

values:
nofollow
external text
//doi.org/10.1155%2F2013%2F946268

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23762867

values:
nofollow
external text
//doi.org/10.18632%2Foncotarget.1549

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24448423

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23442605

values:
nofollow
external text
//doi.org/10.1038%2Fnature14173

values:
nofollow
external text
//www.worldcat.org/issn/0028-0836

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25707793

values:
nofollow
external text
//www.worldcat.org/issn/2211-1247

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25456125

values:
nofollow
external text
//doi.org/10.1016%2Fj.cell.2013.03.025

values:
nofollow
external text
//www.worldcat.org/issn/1097-4172

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23622243

values:
nofollow
external text
//doi.org/10.1016%2Fj.cell.2017.07.003

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/28753428

values:
nofollow
external text
//doi.org/10.1038%2Fnbt.2778

values:
nofollow
external text
//www.worldcat.org/issn/1087-0156

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24336318

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11779493

values:
nofollow
external text
//doi.org/10.1021%2Fcr040481v

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16464022

values:
nofollow
external text
//doi.org/10.1002%2Far.b.20089

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16437551

values: -moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;

values:
plainlist
padding:0 0.1em 0.4em;text-align:left;

values: float:right;clear:right;width:auto;margin:0 0 1.0em 1.0em;background:#f9f9f9;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%

values: position: absolute; top: 0px; left: 100px; right: 0px; bottom: 0px; height: 0px; width: 0px;

values: left: 50%; top: 50%; margin-left: -35px; margin-top: -27.5px;

values:
mwPlayerContainer k-player videoHolder
width: 200px; position: relative;

values:
float: left; margin-left: 5px;
floatnone

values:
/wiki/Wikipedia:Media_help
mw-redirect
Wikipedia:Media help

values: font-size: xx-small; line-height: 1.6em; margin-left: 60px;

values: Template talk:DNA repair (page does not exist)

values:
/wiki/Poly_ADP_ribose_polymerase
mw-redirect
Poly ADP ribose polymerase

values:
/wiki/Transcription-coupled_repair
mw-redirect
Transcription-coupled repair

values: nowraplinks hlist collapsible autocollapse navbox-inner

values:
noprint metadata navbox
navigation
Portals
font-weight:bold;padding:0.4em 2em

values: Category:All articles with dead external links

values: Category:Articles with dead external links from December 2016

values: Category:Articles with permanently dead external links

values: Category:Wikipedia articles needing page number citations from December 2014

values: Category:Wikipedia indefinitely move-protected pages

values: Category:Pages using div col with deprecated parameters

values: Category:Articles with hAudio microformats

values: Category:Articles containing video clips

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/DNA_repair
View the content page [ctrl-alt-c]
c

values: Guidance on how to use and edit Wikipedia

values: About the project, what you can do, where to find things

values: A list of recent changes in the wiki [ctrl-alt-r]

values: portal navigation p-interaction p-interaction-label

values: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

values: Recent changes in pages linked from this page [ctrl-alt-k]

values:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

values: A list of all special pages [ctrl-alt-q]

values: Permanent link to this revision of the page

values: Link to connected data repository item [ctrl-alt-g]

values: Printable version of this page [ctrl-alt-p]

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values: ترميم الدنا – Arabic

values: Рэпарацыя ДНК – Belarusian

values: ДНК корекция – Bulgarian

values: interlanguage-link interwiki-ca badge-Q17437796 badge-featuredarticle

values: بازسازی دی‌ان‌ای – Persian

values: interlanguage-link interwiki-gl badge-Q17437796 badge-featuredarticle

values: ԴՆԹ-ի ռեպարացիա – Armenian

values: დნმ-ის რეპარაცია – Georgian

values: Репарация – Kyrgyz

values: interlanguage-link interwiki-pl badge-Q17437798 badge-goodarticle

values: Репарация ДНК – Russian

values: ඩීඑන්ඒ අළුත්වැඩියාව – Sinhala

values: டி என் ஏ சீராக்கம் – Tamil

values: การซ่อมแซมดีเอ็นเอ – Thai

values: Репарація ДНК – Ukrainian

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-DNA_repair rootpage-DNA_repair skin-vector action-view